missing translation for 'onlineSavingsMsg'
Learn More

Gibco™ Human Activin A Recombinant Protein DFS Item

Recombinant Protein

$556.00 - $14870.00

Specifications

Accession Number P08476, Q04998
For Use With (Application) Bioactivity
Formulation PBS with no preservative
Gene ID (Entrez) 16323, 3624
Molecular Weight (g/mol) 25 kDa
View More Specs

Products 3
Catalog Number Mfr. No. Quantity Price Quantity  
Catalog Number Mfr. No. Quantity Price Quantity  
PHC9561 DFS Item
View Documents
Gibco™
PHC9561
100 μg
Each for $3,980.00
Only null left
 
PHC9563 DFS Item
View Documents
Gibco™
PHC9563
1 mg N/A
N/A
Please call Customer Service at 1-800-234-7437 or send an email to help@thermofisher.com for assistance.
PHC9564 DFS Item
View Documents
Gibco™
PHC9564
10 μg
Each for $556.00
Only null left
 
Description

Description

Carrier-Free Reconstitution: We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute lyophilized recombinant human Activin A in sterile PBS containing 0.1% human serum albumin. Further dilutions should be made in low endotoxin medium or a buffered solution containing a carrier protein such as heat inactivated FCS or tissue culture grade BSA. Storage: Store this lyophilized preparation at = -20°C, preferably desiccated. Upon reconstitution, apportion into working aliquots and store at = -20°C. Avoid repeated freeze/thaw cycles.

Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Activin A mutations are associated with fibrodysplasia ossificans progressive.
Specifications

Specifications

P08476, Q04998
PBS with no preservative
25 kDa
Purified
RUO
activin A; activin beta-A chain; BMP7; BMP-7; Bone morphogenetic protein 7; EDF; Eptotermin alfa; erythroid differentiation factor; erythroid differentiation protein; follicle-stimulating hormone-releasing protein; FRP; FSH-releasing protein; INHB; Inhba; inhibin B subunit; inhibin beta A chain; inhibin beta A protein; inhibin beta A subunit; inhibin beta-A; inhibin beta-A-subunit; inhibin beta-subunit; inhibin subunit beta A; inhibin, beta A; inhibin, beta A (activin A, activin AB alpha polypeptide); Inhibin, beta-1; OP1; OP-1; Osteogenic protein 1; unnamed protein product
Inhba
Protein
Human
-20°C
ED50 = 0.5 - 5 ng/mL; determined by the dose-dependent proliferation of MPC-11 cells.
<1 EU/ml
HEK293 cells
Recombinant, Ligand
Activins
Gibco
Bioactivity
16323, 3624
Human Activin A
-20°C
<1 EU/mL
Activin A
ED50 = 0.5 - 5 ng/mL; determined by the dose-dependent proliferation of MPC-11 cells.
Unconjugated
Recombinant
Carrier-Free
Inhibition of Proliferation of MPC11 cells
Dry Ice
Growth Factors & Receptors
Lyophilized
Neurobiology, Stem Cell Research, Differentiation
>95% by SDS-PAGE
Videos
SDS
missing translation for 'documents'

missing translation for 'documents'